TNFSF10 and lung carcinoma: Desipramine and TRAIL in combination stimulated apoptosis in TRAIL-resistant A549 cells, suggesting that desipramine treatment enhanced TRAIL-induced cancer cell death, specifically in TRAIL-resistant lung cancer cells.